AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 175 filers reported holding AMAG PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 2.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $1,764,000 | +16.7% | 80,000 | +6.7% | 1.58% | +10.7% |
| Q1 2018 | $1,511,000 | +153.5% | 75,000 | +66.7% | 1.43% | +130.9% |
| Q4 2017 | $596,000 | +115.2% | 45,000 | +200.0% | 0.62% | +102.3% |
| Q3 2017 | $277,000 | +0.4% | 15,000 | 0.0% | 0.31% | -16.6% |
| Q2 2017 | $276,000 | -4.5% | 15,000 | +17.1% | 0.37% | +18.4% |
| Q1 2017 | $289,000 | -88.6% | 12,813 | -82.4% | 0.31% | -90.4% |
| Q4 2016 | $2,534,000 | -5.8% | 72,813 | -33.7% | 3.24% | +14.1% |
| Q3 2016 | $2,691,000 | +277.4% | 109,813 | +268.3% | 2.84% | +181.9% |
| Q2 2016 | $713,000 | -23.5% | 29,813 | -25.1% | 1.01% | +49.7% |
| Q1 2016 | $932,000 | +196.8% | 39,813 | +282.8% | 0.67% | +223.1% |
| Q4 2015 | $314,000 | -24.0% | 10,400 | 0.0% | 0.21% | -24.9% |
| Q3 2015 | $413,000 | – | 10,400 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bleichroeder LP | 1,299,994 | $12,220,000 | 2.19% |
| Camber Capital Management LP | 8,780,000 | $82,532,000 | 2.18% |
| Palo Alto Investors LP | 3,003,875 | $28,236,000 | 1.55% |
| ARMISTICE CAPITAL, LLC | 4,120,000 | $38,728,000 | 1.40% |
| Permanens Capital L.P. | 359,311 | $3,378,000 | 1.17% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 31,582 | $297,000 | 0.21% |
| BOOTHBAY FUND MANAGEMENT, LLC | 348,000 | $3,271,000 | 0.20% |
| Teza Capital Management LLC | 20,300 | $191,000 | 0.11% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 767,135 | $7,211,000 | 0.08% |
| Livforsakringsbolaget Skandia, Omsesidigt | 38,800 | $365,000 | 0.04% |